Lifecore Biomedical
LFCR
LFCR
92 hedge funds and large institutions have $149M invested in Lifecore Biomedical in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 28 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.19% less ownership
Funds ownership: 83.6% → 83.41% (-0.19%)
32% less capital invested
Capital invested by funds: $220M → $149M (-$71.4M)
95% less call options, than puts
Call options by funds: $21K | Put options by funds: $389K
Holders
92
Holding in Top 10
5
Calls
$21K
Puts
$389K
Top Buyers
| 1 | +$6.02M | |
| 2 | +$1.08M | |
| 3 | +$543K | |
| 4 |
CSC
Cove Street Capital
El Segundo,
California
|
+$374K |
| 5 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
+$345K |
Top Sellers
| 1 | -$7.5M | |
| 2 | -$476K | |
| 3 | -$447K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$343K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$290K |